First mRNA Flu Shot Approved for Seniors

The first mRNA flu vaccine is now approved for use in older adults, adding a new protection option to the seasonal flu lineup. This shot uses messenger‑RNA technology, the same platform that powered recent COVID‑19 vaccines. Health officials say the mRNA flu shot joins existing flu vaccines, which already include a nasal spray that can be ordered by mail. The new option aims to boost immunity in seniors, a group that faces higher risk of serious flu complications. No other age groups were mentioned in the announcement. Availability will begin this flu season, with distribution coordinated through regular vaccination channels.